Cystic fibrosis in an autosomal recessive disease in humans. Mr. and Mrs. Doe are both heterozygous for a low penetrance disease allele, CFTR Arg117His. The estimated penetrance of the disease is 10%. What is the likelihood that their first child will not be affected?

The answer is 97.5% but I do not understand how. Please show me!

answer

watching

178

views

For unlimited access to Homework Help, a Homework+ subscription is required.

You have 0 free answers left.
Get unlimited access to 3.8 million step-by-step answers.

Get unlimited access

Already have an account? Log in

Sixta KovacekLv2

17 Jun 2019

Unlock all answers

Get 1 free homework help answer.

Already have an account? Log in

Related questions

1) You have been hired as a genetic counselor. Your first patient is a young woman named Lei who comes to you because her brother has cystic fibrosis. (Learn more about this disease in the PowerPoint slides â find out how it is inherited, is it dominant or recessive?) Lei is healthy but would like to know the risk that she is a carrier for the disease. Both her parents are healthy as is her older sister. a. Fill in the Punnett Square below with her parentâs genotypes to predict her risk of being a carrier of cystic fibrosis. You should be able to determine her parentâs genotypes from information given above. Male/ Female b. Explain to Lei her risk of being a carrier: 2). A blood DNA test for the cystic fibrosis allele becomes available and you recommend to Lei that she take the blood test and that her FiancÃ© Robert take the test as well. Leiâs test shows that she is a carrier. Robert is not. What is the risk that their future child will have cystic fibrosis? a. Use the Punnett Square below to predict Lei and Robertâs risk of having a child with CF? Male/ Female b. Write down your explanation to Lei and her FiancÃ©: 3. Another patient, Mark, comes to you because his father has just been diagnosed with the rare genetic disorder known as Huntingtonâs disease. Mark would like to know his potential risk of developing the disease (you must read about the inheritance pattern of Huntingtonâs disease in the Lecture and online games to answer this correctly!). Assume that his mother is showing no signs of Huntingtonâs disease. a. Fill in the Punnett Square below to predict Markâs risk of getting Huntingtonâs disease. Male/ Female b. Your explanation to Mark:

Sandra and Steven are expecting their first child. Each have one female sibling who is affected with PKU (Phenylketonurea) and no other family history of the disorder is known on either side. They ask what their risk is of having an affected child. What do you tell them? A) They must both be heterozygotes so their risk of having an affected child is 25%.

B) There is a 50% chance they are heterozygous carriers so they should get genetic testing.

C) Since neither one of them is affected, they are not at risk of having an affected child.

D) You can't give them any firm answers because you don't know their genotypes.

E) Since this disorder is an autosomal recessive no one in the next generation will have the disease.

Cystic Fibrosis (CF) is an autosomal recessive genetic disease that is characterized by the secretion of thick, abnormal mucous in the lungs. The mutated gene that leads these symptoms is the CF transmembrane conductance regulator (CFTR gene). The encoded protein is a chloride channel that moves chloride ions out of epithelial cells. In a homozygous individual, the lack of this chloride channel function in a mutant slows the flow of water into extracellular spaces. This lack of water export leads to the heavy mucus in the lungs of CF patients. Although children with CF would die in childhood, current treatments provide life expectancies into the 30âs.

CF is the most frequently inherited genetic disorder among American children. It affects 1 of every 2,500 children; 30,000 currently have the disease. Although its frequency is higher in European populations, it affects all human populations. Heterozygous carrier frequencies in the US are estimated to be 1 out of 29 Caucasians, 1 out of 46 Hispanics, 1 out of 61 African Americans and 1 out of 90 Asians. There are genetic screens for carriers of CF but they are not routinely performed despite this high frequency of carriers. At least all states in the US proscribe testing of newborns to identify children with CF early so that treatment can be started. Newborn tests for CF: http://www.cff.org/AboutCF/Testing/NewbornScreening/ScreeningforCF/ . If CF is such a common genetic disease, and such a simple Mendelian trait, why is genetic screening of parents not done more frequently? Is it just economic, a pain to do, or is it more complex such that the results of genetic testing are not just positive or negative?

Answer the following questions:
1. If two parents are heterozygous carriers of CF, show a pedigree with four children showing the incidence of carriers and afflicted children. If each unafflicted child (carrier or not) mates with another person, who has a 1 out of 30 chance of being a carrier of CF, what is the expected incidence CF disease in the third generation (frequency of CF in any one of grandchildren of the original couple)?

2. Pleiotropy of Cystic Fibrosis. Watch the two videos on the left at:

http://www.cftrscience.com/MOD-animation
or, if you can not view these, read the short NIH Genetics Home Reference for Cystic Fibrosis http://ghr.nlm.nih.gov/condition/cystic-fibrosis

Connect the description with one of the following videos, or related ones (there are many) you see:
video (10 minutes) of daily life of a child with Cystic Fibrosis http://www.youtube.com/watch?v=WUsuGKzdDg8
Lauraâs (20 year old) video diary of life with CF http://www.youtube.com/watch?v=Pgrf8qJXhpc&feature=related

In your own words, describe the range of CF phenotypes. List the other organs besides lungs that are affected and how does it affects those organs.

3.The DNA sequence of the CFTR gene is 170,000 base pairs in length and encodes the CFTR protein that is 1480 amino acids long. Open the accompanying text file (in Canvas/Files/Discussion folder) âCFTR gene DNA sequenceâ. You will see an alignment of the NIH human genome sequence of the CFTR gene â called âReferenceâ rather than âwild-typeâ- against a gene sequence containing a common mutation in CFTR. Look at the alignment and determine how the DNA sequence differs between them. What is the position number where they differ? How many and what nucleotides do they differ in? A â-â mark in one sequence in the alignment means that that base sequence is missing the corresponding bases in the other sequence. The sequence is a long one but the differences are in bolded bright red text. Matching sequence is marked with a | linking the two sequences. Look near the sequence AAATATCATC if you use FIND tool in Word.

In another file, you will an alignment of the reference translated into a protein sequence, compared to the mutant allele translated into protein sequence. The differences are again in red whereas the areas where the proteins match are in black. Look at the alignment. How do these two proteins differ? Again, find the position number and describe how they differ at that location. A â-â mark in the alignment means that amino acid is missing when compared to the other sequence.

4. Given that the CFTR gene can be analyzed for a mutation that causes CF, couples interested in being tested as carriers face several choices given the results.
What could be a consequence of a false positive result (couple is identified as carriers but they would not produce any children with symptoms)?

What could be a consequence of a false negative result (a test indicates the couple is not both carriers but they would produce some children with CF)?

5. The sensitivity of the test can vary with ethnic group. The following is a chart from the NCBI Genetic testing site. A sensitivity less than 100% would be likely to produce false negative results from an inability to determine that someone is carrier.

CF Carrier Test Sensitivity by Ethnic Group http://www.ncbi.nlm.nih.gov/projects/GeneTests/static/concepts/primer/ptscarr5.shtml
Ethnic Group ¹	Population Frequency of CF	Sensitivity of Carrier Detection ²
Caucasian	1 in 29	90%
Ashkenazi Jewish	1 in 29	97%
Native American	1 in 32	94%
Latino	1 in 46	57%
African-American	1 in 60	75%
Asian	1 in 90	30%